U.S. arms sale to Israel triggers congressional review
The State Department on Tuesday notified Congress of a $2.8 billion U.S. arms sale to Israel that would deliver 40,000 two‑thousand‑pound bombs, the largest conventional explosive ordnance transfer to the country in years. The notification triggers a review by the Senate Foreign Relations Committee and the House Foreign Affairs Committee, both of which must approve the sale before any munitions can leave U.S. depots.
The package includes 20,000 MK‑84 general‑purpose bombs and 20,000 BLU‑117 penetrator bombs, each weighing about 2,000 lb. Together the munitions total roughly 40,000 tons, a weight the Washington Post compared to the tonnage dropped on Berlin during the largest U.S. raid of World War II. The sale was first reported by the Washington Post on 15 September 2026 and confirmed by officials familiar with the transaction.
The proposed transfer follows a policy reversal by the Trump administration. In 2024 the Biden administration paused a similar shipment after humanitarian concerns were raised. After taking office in early 2025, the Trump administration lifted that pause, according to the Manila Times.
Congressional oversight now hinges on the Senate Foreign Relations Committee, chaired by Jim Risch with Jeanne Shaheen as ranking member, and the House Foreign Affairs Committee, chaired by Brian Mast with Gregory Meeks as ranking member. Neither committee has issued a public statement on the sale, and a timeline for a vote remains unclear.
If approved, the bombs would join a broader $7.4 billion of U.S. arms sales to Israel in 2025, which already included earlier deliveries of MK‑84 munitions. For the Israeli Defense Forces, the influx could increase the ability to strike hardened underground facilities, particularly with the BLU‑117 penetrator, and expand the volume of high‑explosive attacks in Gaza and along the Lebanon border.
Humanitarian groups warn that the larger bombs could raise the risk of civilian casualties and infrastructure damage. Israeli officials have reported more than 70,000 civilian deaths in Gaza, a figure cited by ZeroHedge. Critics also note that diverting such a large quantity of 2,000‑lb bombs could strain U.S. stockpiles already taxed by operations in the Middle East, potentially affecting readiness for other contingencies.
U.S. defense contractors stand to profit from the sale, adding another dimension to the debate over the balance between strategic support for an ally and the moral costs of intensified bombing. Lawmakers will weigh the operational benefits to Israel against the potential for heightened civilian harm and the broader implications for U.S. arms policy.
Until both committees vote to approve the transfer, the sale cannot proceed. The pending decision underscores the ongoing tension in Washington between supporting Israel’s military objectives and addressing humanitarian concerns raised by the conflict.